A subcutaneous injection site fixing card for the abdomen
By designing a fixing card for the abdomen subcutaneous injection site including a transparent positioning plate, an auxiliary plate and an injection window, the problem of difficulty in accurate insulin injection position is solved, and the accuracy and safety of the injection position are achieved.
Patent Information
- Application Number
- CN202420760818.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-14
- Publication Date
- 2025-04-11
- Estimated Expiration
- 2034-04-14
AI Technical Summary
During insulin injection, it is difficult for patients to find the injection location accurately, resulting in a deviation in the injection location and may cause adverse reactions.
Design a abdominal subcutaneous injection site fixation card, including a transparent positioning plate, auxiliary plate and injection window, to help accurately position with positioning marks and indicator arrows, and to prevent contamination through adhesion film.
The accuracy of the insulin injection position is achieved, adverse reactions caused by position deviation are avoided, the structure is simple and the operation is convenient, and the convenience and safety of injection is improved.
Smart Images
Figure CN222738331U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of insulin injection, in particular to a subcutaneous abdominal injection site fixing card. Background Art
[0002] Insulin injection is used for: 1. Type I diabetes. 2. Type II diabetes with severe infection, trauma, major surgery and other severe stress, as well as combined cardiovascular and cerebrovascular complications, kidney or retinal diseases. 3. Diabetic ketoacidosis, hyperglycemia and non-ketotic hyperosmolar coma. 4. Long-term type II diabetes with low plasma insulin levels, unsatisfactory control through reasonable diet, physical activity and oral hypoglycemic drugs, and type II diabetes with contraindications to oral hypoglycemic drugs, such as pregnancy and breastfeeding. 5. Adult or elderly diabetic patients with acute onset, significant weight loss and obvious emaciation. 6. Gestational diabetes. 7. Diabetes secondary to severe pancreatic disease. 8. For severe malnutrition, emaciation, intractable vomiting during pregnancy, and early stage of cirrhosis, glucose and small doses of insulin can be intravenously dripped at the same time to promote tissue utilization of glucose.
[0003] The main effect of insulin is to lower blood sugar and affect protein and fat metabolism. However, since it is easily broken down by gastrointestinal digestive enzymes when taken orally, subcutaneous injection is usually chosen to allow rapid absorption of the drug. For diabetic patients, insulin injections can be done by themselves or by going to the hospital for injections by a doctor. The injection site is generally centered on the navel, 3-5 cm to the left and right of the navel. Deviations in the injection site can easily cause adverse reactions, especially when patients inject the drug themselves at home. Due to the inconvenient position to observe, it is easy to fail to find the injection site accurately, resulting in position deviation when injecting the drug.
[0004] Therefore, a subcutaneous abdominal injection site fixing card is needed to facilitate medical staff or patients to accurately find the injection site for liquid medicine injection. Utility Model Content
[0005] In order to solve the above problems, the utility model provides an abdominal subcutaneous injection site fixing card, which has the characteristics of convenient operation and simple structure.
[0006] In order to achieve the above purpose, the utility model proposes the following specific solutions:
[0007] A fixing card for a subcutaneous injection site in the abdomen comprises a fixing card, wherein the fixing card comprises a transparent positioning plate, an auxiliary plate is provided on the outer fixing sleeve of the transparent positioning plate, a dividing mark is symmetrically provided on one side wall of the auxiliary plate, an indication panel is provided on one side of the dividing mark, an indication arrow is provided on the indication panel, an injection panel is provided on the other side of the dividing mark, an injection window is provided on the injection panel, a sterile film is fixedly provided on the inner side of the injection window, the injection window is two centimeters long, and the straight-line distance between the end of the injection window close to the transparent positioning plate and the outer circle of the transparent positioning plate is three centimeters.
[0008] As a preferred technical solution of the abdominal subcutaneous injection site fixing card of the utility model, a first adhesive film is adhered to one side wall of the fixing card, and the first adhesive film is adhered to the outer side of the injection window.
[0009] As a preferred technical solution of the abdominal subcutaneous injection site fixing card of the utility model, a first protruding piece is fixedly provided at one end of the first adhesive film.
[0010] As an optimal technical solution for an abdominal subcutaneous injection site fixing card of the utility model, a first adhesive rubber ring is fixedly provided on the edge of the other side wall of the auxiliary plate, a second adhesive rubber ring is fixedly provided on the middle of the other side wall of the auxiliary plate, and a second adhesive film is provided on one side of the auxiliary plate.
[0011] As a preferred technical solution of the abdominal subcutaneous injection site fixing card of the utility model, the second adhesive film is adhered to the first adhesive rubber ring and the second adhesive rubber ring.
[0012] As a preferred technical solution of the abdominal subcutaneous injection site fixing card of the utility model, a second protruding piece is fixedly provided on the top of the second adhesive film.
[0013] As a preferred technical solution of the abdominal subcutaneous injection site fixing card of the utility model, a positioning mark is provided in the middle of one side wall of the transparent positioning plate.
[0014] As a preferred technical solution of the abdominal subcutaneous injection site fixing card of the utility model, the indication panel is symmetrically arranged up and down, and the injection panel is symmetrically arranged left and right.
[0015] Compared with the existing technology, the utility model has the following beneficial effects:
[0016] The utility model provides a fixing card, and a positioning plate of transparent material is provided in the middle of the fixing card, and a positioning mark is provided on the fixing plate, which is convenient for the patient to align the center of the fixing card with the navel for fixing and placing. An auxiliary plate is provided on the outer side of the positioning plate. After the fixing card is fixed on the navel, the patient or medical staff can judge whether the fixing card is accurately placed according to the indicating arrow on the auxiliary plate. After the upper and lower positions of the indicating arrows are accurate, the medical staff or the patient can inject through the injection window on the auxiliary plate. The injection windows are symmetrically arranged on the left and right, and are located at 2.5-5 cm on the left and right, so that the patient or the medical staff can find the injection position accurately and quickly for liquid injection, and avoid the conventional direct injection method, which is easy to cause adverse reactions in the patient due to the deviation of the injection position. The overall structure is simple, and the injection window has a certain length, which is convenient for adjusting the specific injection position according to the patient's body shape, and the operation is convenient;
[0017] In addition, by adhering the first adhesive film to the outer side of the injection window and adhering the second adhesive film to the other side of the fixing card, it is prevented that the fixing card is contaminated when not in use, resulting in the contamination of the injection needle during injection, thereby improving the safety of use. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] In order to better describe the technical solution of the utility model in detail, the present invention is further explained below in conjunction with the accompanying drawings and embodiments.
[0019] Figure 1 It is a schematic diagram of the overall structure provided by the utility model;
[0020] Figure 2 It is a three-dimensional schematic diagram of the fixing card of the utility model;
[0021] Figure 3 It is a three-dimensional cross-sectional view of the fixing card and the second adhesive film of the utility model;
[0022] Figure 4 For the utility model Figure 3 The enlarged schematic diagram of point A in the middle;
[0023] Figure 5 For the utility model Figure 3 A magnified schematic diagram of point B in the middle.
[0024] In the figure: 1. fixing card; 11. transparent positioning plate; 111. positioning mark; 12. auxiliary plate; 13. segmentation mark; 14. indication panel; 141. indication arrow; 15. injection panel; 151. injection window; 152. sterile film; 16. first adhesive rubber ring; 17. second adhesive rubber ring; 2. first adhesive film; 21. first protruding piece; 3. second adhesive film; 31. second protruding piece. DETAILED DESCRIPTION
[0025] The following will be combined with the drawings in the embodiments of the utility model to clearly and completely describe the technical solutions in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, not all of the embodiments. Based on the embodiments of the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.
[0026] Example
[0027] See also Figure 1-5 As shown, the utility model provides the following technical solutions: a fixing card for subcutaneous injection site in the abdomen, comprising a fixing card 1, the fixing card 1 comprising a transparent positioning plate 11; a positioning mark 111 is provided in the middle of one side wall of the transparent positioning plate 11, the positioning mark 111 is also transparent, and is convenient for accurately positioning the fixing card 1 at the navel position of the patient, and can refer to the attached Figure 3 As shown; the outer fixed sleeve of the transparent positioning plate 11 is provided with an auxiliary plate 12, and a dividing mark 13 is symmetrically provided on one side wall of the auxiliary plate 12. An indication panel 14 is provided on one side of the dividing mark 13, and an indication arrow 141 is provided on the indication panel 14. The color of the indication arrow 141 is red, which is convenient for reminding the patient to use it correctly and for adjusting the position of the fixed card 1 according to the indication arrow 141, so as to facilitate accurate injection. An injection panel 15 is provided on the other side of the dividing mark 13, and an injection window 151 is opened on the injection panel 15. A sterile film 152 is fixed on the inner side of the injection window 151 to facilitate syringe puncture. Please refer to the attached Figure 2 The first adhesive rubber ring 16 is fixed to the edge of the other side wall of the auxiliary plate 12, and the second adhesive rubber ring 17 is fixed to the middle of the other side wall of the auxiliary plate 12. Figure 4 With attached Figure 5 , used to adhere the fixing card 1 near the patient's navel; the indication panel 14 is symmetrically arranged up and down, and the injection panel 15 is symmetrically arranged left and right; this solution uses the setting of the fixing card 1, after the fixing card 1 is adhered to the patient's navel, the symmetrical indication arrows 141 point to the up and down directions for calibration, and then the patient or medical staff can accurately perform insulin injection through the left and right symmetrical injection windows 151, avoiding the conventional direct injection method that is prone to position deviation and causes adverse reactions in patients. The structure is simple, the operation is convenient, and the convenience of insulin injection is improved.
[0028] Reference Figure 2 and Figure 3As shown, specifically, the injection window 151 is two centimeters long, and the straight-line distance between one end of the injection window 151 close to the transparent positioning plate 11 and the outer circle of the transparent positioning plate 11 is 2.5 centimeters; the length of the injection window 151 meets the standard for insulin injection, that is, 2.5-5 centimeters around the navel, and the patient can inject at an appropriate position inside the injection window 151 according to his or her own situation.
[0029] Reference Figure 1 and Figure 4 As shown, specifically, a first adhesive film 2 is adhered to one side wall of the fixed card 1, and the first adhesive film 2 is adhered to the outer side of the injection window 151, so as to protect the injection window 151 and avoid contamination; a first protruding piece 21 is fixedly provided at one end of the first adhesive film 2, so as to facilitate the removal of the first adhesive film 2; a second adhesive film 3 is provided on one side of the auxiliary plate 12, so as to protect the other side of the fixed card 1; the second adhesive film 3 is adhered to the first adhesive rubber ring 16 and the second adhesive rubber ring 17; a second protruding piece 31 is fixedly provided on the top of the second adhesive film 3, so as to facilitate the removal of the second adhesive film 3; this scheme realizes the protection of the fixed card 1 by setting the adhesive film, so as to avoid the situation that the injection safety is affected after the fixed card 1 is contaminated.
[0030] The working principle and use process of the utility model are as follows: when the patient needs to inject insulin, the second adhesive film 3 on one side of the fixing card 1 is peeled off, and the transparent positioning plate 11 is aligned with the navel through the positioning mark 111, and at the same time, it is observed whether the indicating arrow 141 is pointing up and down. After the position is accurate, the fixing card 1 is adhered to the patient's navel position through the first adhesive rubber ring 16 and the second adhesive rubber ring 17, and then the patient removes the first adhesive film 2 on the injection window 151, and then the patient injects the syringe filled with insulin solution through the injection window 151. The operation is convenient and the injection position is accurate.
[0031] Finally, it should be noted that the above description is only a preferred embodiment of the utility model and is not intended to limit the utility model. Although the utility model is described in detail with reference to the above embodiments, those skilled in the art can still modify the technical solutions recorded in the above embodiments or replace some of the technical features therein by equivalents. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the utility model shall be included in the protection scope of the utility model.
Claims
1. A fixing card for a subcutaneous injection site in the abdomen, comprising a fixing card (1), characterized in that: The fixing card (1) comprises a transparent positioning plate (11), an auxiliary plate (12) is fixedly mounted on the outer side of the transparent positioning plate (11), a dividing mark (13) is symmetrically arranged on one side wall of the auxiliary plate (12), an indication panel (14) is arranged on one side of the dividing mark (13), an indication arrow (141) is arranged on the indication panel (14), an injection panel (15) is arranged on the other side of the dividing mark (13), an injection window (151) is opened on the injection panel (15), a sterile film (152) is fixedly arranged on the inner side of the injection window (151), the injection window (151) is two centimeters long, and the straight-line distance between the end of the injection window (151) close to the transparent positioning plate (11) and the outer circle of the transparent positioning plate (11) is three centimeters.
2. The abdominal subcutaneous injection site fixing card according to claim 1, characterized in that: A first adhesive film (2) is adhered to one side wall of the fixing card (1), and the first adhesive film (2) is adhered to the outer side of the injection window (151).
3. The abdominal subcutaneous injection site fixing card according to claim 2, characterized in that: A first protruding piece (21) is fixedly provided at one end of the first adhesive film (2).
4. The abdominal subcutaneous injection site fixing card according to claim 3, characterized in that: A first adhesive rubber ring (16) is fixedly provided at the edge of the other side wall of the auxiliary plate (12), a second adhesive rubber ring (17) is fixedly provided at the middle of the other side wall of the auxiliary plate (12), and a second adhesive film (3) is provided on one side of the auxiliary plate (12).
5. The abdominal subcutaneous injection site fixing card according to claim 4, characterized in that: The second adhesive film (3) is adhered to the first adhesive rubber ring (16) and the second adhesive rubber ring (17).
6. The abdominal subcutaneous injection site fixing card according to claim 5, characterized in that: A second protruding piece (31) is fixedly provided on the top of the second adhesive film (3).
7. The abdominal subcutaneous injection site fixing card according to claim 6, characterized in that: A positioning mark (111) is provided in the middle of one side wall of the transparent positioning plate (11).
8. The abdominal subcutaneous injection site fixing card according to claim 7, characterized in that: The indication panel (14) is arranged symmetrically up and down, and the injection panel (15) is arranged symmetrically left and right.